Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. It also manufactures and develops nanostrain biosensors for measuring pressure and temperature in live tissue. The company was founded in 2006 and is headquartered in Bergen, Norway.
Stock data | 2024 | Change |
---|---|---|
Price | $1.19 | N/A |
Market Cap | $159.93M | N/A |
Shares Outstanding | 134.87M | N/A |
Employees | 25.00 | N/A |